Accessing the genomic effects of naked nanoceria in murine neuronal cells

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 5, 2012, Pages 599-608

  Lee, Tin Lap ^a,c   Raitano, Joan M ^b   Rennert, Owen M ^a   Chan, Siu Wai ^b   Chan, Wai Yee ^a,c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b Fu Foundation School of Engineering and Applied Science   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cerium oxide; Genomics; Nanoceria; Nanoparticles; Neuronal cells

Indexed keywords

ANTIOXIDANTS; CYTOLOGY; DISEASE CONTROL; NANOPARTICLES; NEURONS; OXIDES; POPULATION STATISTICS; TRANSCRIPTION;

CERIUM OXIDE NANOPARTICLE; ENGINEERED NANOPARTICLES; FUNCTIONAL GENOMICS; GENE TRANSCRIPTIONS; GENOMICS; NANO-CERIA; NEUROLOGICAL DISEASE; NEURONAL CELL;

CERIUM OXIDE;

CERIUM OXIDE; NANOPARTICLE;

ARTICLE; CELL CYCLE REGULATION; CELL GROWTH; CELL SIZE; CONTROLLED STUDY; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENETIC TRANSCRIPTION; NERVE CELL; NEUROLOGIC DISEASE; TRANSCRIPTOMICS; WESTERN BLOTTING;

MURINAE;

EID: 84862637672     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.08.005     Document Type: Article

References (54)

1. Gao F., Lu Q., Komarneni S. Fast synthesis of cerium oxide nanoparticles and nanorods. J Nanosci Nanotechnol 2006, 6:3812-3819.
2. Mogensen M., Sammes N.M., Tompsett G.A. Physical, chemical and electrochemical properties of pure and doped ceria. Solid State Ionics 2000, 129:63-94.
3. Greenwood N.N., Earnshaw A. Chemistry of the elements 1989, Pergamon Press, Oxford.
4. 2S. Catal Today 2003, 81:659-671.
5. Mamontov E., Egami T., Brezny R., Koranne M., Tyagi S. Lattice defects and oxygen storage capacity of nanocrystalline ceria and ceria-zirconia. J Phys Chem B 2000, 104:11110-11116.
6. Boaro M., Vicario M., Leitenburg C.D., Dolcetti G., Trovarelli A. The use of temperature-programmed and dynamic/transient methods in catalysis: characterization of ceria-based, model three-way catalysts. Catal Today 2003, 77:407-417.
7. 2. J Porous Mater 2008, 15:519-525.
8. Suda A., Yamamura K., Sobukawa H., Ukyo Y., Tanabe T., Nagai Y., et al. Effect of the amount of Pt loading on the oxygen storage capacity of ceria-zirconia solid solution. J Ceram Soc Jpn 2004, 112:623-627.
9. 2-delta: A new non-deactivating catalyst for hydrogen production via water-gas shift reaction. Appl Catal B-Environ 2010, 99:279-288.
10. Yao H.C., Yao Y.F.Y. Ceria in automotive exhaust catalysts. 1. Oxygen storage. J Catal 1984, 86:254-265.
11. Tschope A. Interface defect chemistry and effective conductivity in polycrystalline cerium oxide. J Electroceram 2005, 14:5-23.
12. 2(110) surface: molecular and dissociative channels. J Phys Chem B 1999, 103:5328-5337.
13. Campbell C.T., Peden C.H.F. Chemistry-oxygen vacancies and catalysis on ceria surfaces. Science 2005, 309:713-714.
14. Das M., Patil S., Bhargava N., Kang J.F., Riedel L.M., Seal S., et al. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 2007, 28:1918-1925.
15. Schubert D., Dargusch R., Raitano J., Chan S.W. Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun 2006, 342:86-91.
16. Tarnuzzer R.W., Colon J., Patil S., Seal S. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett 2005, 5:2573-2577.
17. Niu J., Azfer A., Rogers L.M., Wang X., Kolattukudy P.E. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res 2007, 73:549-559.
18. 2 nanoparticles for Escherichia coli. Physico-chemical insight of the cytotoxicity mechanism. Environ Sci Technol 2006, 40:6151-6156.
19. Lin W., Huang Y.W., Zhou X.D., Ma Y. Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int J Toxicol 2006, 25:451-457.
20. Park E.J., Choi J., Park Y.K., Park K. Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology 2008, 245:90-100.
21. Zhang F., Chan S.W., Spanier J.E., Apak E., Jin Q., Robinson R.D., et al. Cerium oxide nanoparticles: size-selective formation and structure analysis. Appl Phys Lett 2002, 80:127-129.
22. Cullity B.D. Elements of x-ray diffraction 1978, Addison Wesley, Boston, MA. 2nd ed.
23. 2 nanoparticles: the effect of particle size. J Am Ceram Soc 2006, 89:1028-1036.
24. Zhang F., Jin Q., Chan S.W. Ceria nanoparticles: size, size distribution, and shape. J Appl Phys 2004, 95:4319-4326.
25. Spanier JE, Robinson RD, Zhang F, Chan S-W, Herman IP. Size-dependent properties of CeO2-y nanoparticles as studied by Raman scattering. Phys Rev B. 2001;64:245407/245401-245408.
26. Perebeinos V., Chan S.W., Zhang F. 'Madelung model' prediction for dependence of lattice parameter on nanocrystal size. Solid State Commun 2002, 123:295-297.
27. Zhang F., Wang P., Koberstein J., Khalid S., Chan S.W. Cerium oxidation state in ceria nanoparticles studied with X-ray photoelectron spectroscopy and absorption near edge spectroscopy. Surf Sci 2004, 563:74-82.
28. Jiang W., Kim B.Y., Rutka J.T., Chan C.W. Nanoparticle-mediated cellular response is size-dependent. Nat Nano 2008, 3:145-150.
29. Duyao M.P., Auerbach A.B., Ryan A., Persichetti F., Barnes G.T., McNeil S.M., et al. Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 1995, 269:407-410.
30. Zeitlin S., Liu J.P., Chapman D.L., Papaioannou V.E., Efstratiadis A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat Genet 1995, 11:155-163.
31. Nasir J., Floresco S.B., O'Kusky J.R., Diewert V.M., Richman J.M., Zeisler J., et al. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 1995, 81:811-823.
32. White J.K., Auerbach W., Duyao M.P., Vonsattel J.P., Gusella J.F., Joyner A.L., et al. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat Genet 1997, 17:404-410.
33. Auerbach W., Hurlbert M.S., Hilditch-Maguire P., Wadghiri Y.Z., Wheeler V.C., Cohen S.I., et al. The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin. Hum Mol Genet 2001, 10:2515-2523.
34. Binet C., Daturi M., Lavalley J.C. IR study of polycrystalline ceria properties in oxidised and reduced states. Catal Today 1999, 50:207-225.
35. Can L., Domen K., Maruya K., Onishi T. Dioxygen adsorption on well-outgassed and partially reduced cerium oxide studied by FT-IR. J Am Chem Soc 1989, 111:7683-7687.
36. Mehta A., Patil S., Bang H., Cho H.J., Seal S. A novel multivalent nanomaterial based hydrogen peroxide sensor. Sens Actuator A-Phys 2007, 134:146-151.
37. Guzman J., Carrettin S., Fierro-Gonzalez J.C., Hao Y.L., Gates B.C., Corma A. CO oxidation catalyzed by supported gold: cooperation between gold and nanocrystalline rare-earth supports forms reactive surface superoxide and peroxide species. Angew Chem Int Edn 2005, 44:4778-4781.
38. 2 catalyst. Appl Catal A-Gen 2009, 360:81-88.
39. 3. J Phys Chem C 2007, 111:2259-2264.
40. 2 nanocrystals with well-defined surface planes by Raman spectroscopy and O-2 adsorption. Langmuir 2010, 26:16595-16606.
41. Nolan M. Healing of oxygen vacancies on reduced surfaces of gold-doped ceria. J Chem Phys 2009, 130:144702.
42. Huang M., Fabris S. Role of surface peroxo and superoxo species in the low-temperature oxygen buffering of ceria: density functional theory calculations. Phys Rev B 2007, 75:081404(R).
43. Trovarelli A. Catalysis by ceria and related materials 2002, Imperial College Press, London.
44. 3. Activation by noble metals. Correlation with oxide basicity. J Phys Chem 1996, 100:9429-9438.
45. 2(111) surfaces. Catal Today 2003, 85:79-91.
46. Kermer P., Liman J., Weishaupt J.H., Bahr M. Neuronal apoptosis in neurodegenerative diseases: from basic research to clinical application. Neurodegen Dis 2004, 1:9-19.
47. Cattaneo E., Zuccato C., Tartari M. Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci 2005, 6:919-930.
48. Roa W., Zhang X., Guo L., Shaw A., Hu X., Xiong Y., et al. Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology 2009, 20:375101.
49. Zhang X., Xing J.Z., Chen J., Ko L., Amanie J., Gulavita S., et al. Enhanced radiation sensitivity in prostate cancer by gold-nanoparticles. Clin Invest Med 2008, 31:E160-E167.
50. Huang Y.H., Zugates G.T., Peng W., Holtz D., Dunton C., Green J.J., et al. Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice. Cancer Res 2009, 69:6184-6191.
51. LA J., Lopez-Viota M., Delgado A.V., Ruiz M.A. 5-Fluorouracil-loaded iron/ethylcellulose (core/shell) nanoparticles for active targeting of cancer. J Drug Target 2009, Retraction in J Drug Target. 2009;17:813. 10.1080/10611860903244207.
52. Baroli B., Ennas M.G., Loffredo F., Isola M., Pinna R., Lopez-Quintela M.A. Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol 2007, 127:1701-1712.
53. Wallace W. Phospholipid lung surfactant and nanoparticle surface toxicity: lessons from diesel soots and silicate dusts. J Nanoparticle Res 2007, 9:23-38.
54. Kreuter J., Shamenkov D., Petrov V., Ramge P., Cychutek K., Koch-Brandt C., et al. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target 2002, 10:317-325.